Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease

Brian J Mickey

doi:10.2217/pgs-2016-0087

Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease

Pharmacogenomics. 2016 Jul;17(11):1207-1210. doi: 10.2217/pgs-2016-0087. Epub 2016 Jul 5.

Author

Brian J Mickey^{1

2}

Affiliations

¹ Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
² Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA.

PMID: 27377823
DOI: 10.2217/pgs-2016-0087

No abstract available

Keywords: Huntington disease; Parkinson disease; bipolar disorder; dopamine receptor; major depressive disorder; molecular imaging; striatum; schizophrenia.

Publication types

Editorial

MeSH terms

Dopamine Antagonists / therapeutic use
Genetic Variation / genetics*
Humans
Mental Disorders / drug therapy*
Mental Disorders / genetics*
Pharmacogenomic Variants / genetics*
Receptors, Dopamine D2 / genetics*
Treatment Outcome

Substances

DRD2 protein, human
Dopamine Antagonists
Receptors, Dopamine D2